Abstract

Adherence to nebulised therapies varies in children with CF. The development of adaptive aerosol device (AAD) systems has facilitated accurate monitoring of adherence to nebulised therapies. The aim of this study was to observe the effect of the first lockdown period of the COVID-19 pandemic, when schools were closed on adherence to nebulised therapies in children with CF.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call